Financhill
Sell
44

ZVRA Quote, Financials, Valuation and Earnings

Last price:
$8.49
Seasonality move :
-0.81%
Day range:
$8.34 - $8.83
52-week range:
$4.20 - $9.76
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
14.75x
P/B ratio:
6.50x
Volume:
2.5M
Avg. volume:
645.5K
1-year change:
78.93%
Market cap:
$453.2M
Revenue:
$27.5M
EPS (TTM):
-$2.11
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $12.8M $13.3M $28.7M $10.2M $27.5M
Revenue Growth (YoY) -- 3.5% 115.61% -64.53% 170.26%
 
Cost of Revenues $2.9M $1.3M $2.1M $222K $2.9M
Gross Profit $9.9M $12M $26.6M $9.9M $24.5M
Gross Profit Margin 77.06% 90.18% 92.81% 97.82% 89.28%
 
R&D Expenses $19.4M $8.8M $10.2M $19.8M $39.8M
Selling, General & Admin $10.8M $7.9M $8.7M $15M $34.3M
Other Inc / (Exp) $2M -$1M -$16.1M -$3.1M $515K
Operating Expenses $30.2M $16.8M $18.9M $34.8M $74.1M
Operating Income -$20.3M -$4.8M $7.7M -$24.9M -$49.6M
 
Net Interest Expenses $6.2M $7M $115K -- --
EBT. Incl. Unusual Items -$24.5M -$12.8M -$8.5M -$26.8M -$46M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$22K -$34K $34K -$33K --
Net Income to Company -$24.5M -$12.8M -$8.6M -$26.8M -$46M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$24.5M -$12.8M -$8.6M -$26.8M -$46M
 
Basic EPS (Cont. Ops) -$13.23 -$3.21 -$2.11 -$0.78 -$1.30
Diluted EPS (Cont. Ops) -$13.23 -$3.21 -$2.11 -$0.78 -$1.30
Weighted Average Basic Share $1.9M $4M $29.8M $34.5M $35.5M
Weighted Average Diluted Share $1.9M $4M $29.8M $34.5M $35.5M
 
EBITDA -$17.7M -$5.4M -$7.9M -$25.5M -$43.5M
EBIT -$18M -$5.7M -$8.1M -$26.5M -$44.5M
 
Revenue (Reported) $12.8M $13.3M $28.7M $10.2M $27.5M
Operating Income (Reported) -$20.3M -$4.8M $7.7M -$24.9M -$49.6M
Operating Income (Adjusted) -$18M -$5.7M -$8.1M -$26.5M -$44.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $1.9M $2M $2.9M $2.9M $3.7M
Revenue Growth (YoY) -83.21% 2.08% 46.26% 0.73% 27.63%
 
Cost of Revenues -- -- $141K $144K $2.3M
Gross Profit $1.9M $2M $2.7M $2.8M $1.4M
Gross Profit Margin -- -- 95.09% 95.03% 37.67%
 
R&D Expenses $1.7M $2.2M $5.4M $12.3M $10.9M
Selling, General & Admin $1.4M $1.9M $4M $5.8M $16.2M
Other Inc / (Exp) -$137K $332K -$117K $3.8M -$4.7M
Operating Expenses $3.1M $4.2M $9.4M $18.1M $28.7M
Operating Income -$1.2M -$2.2M -$6.6M -$15.4M -$27.3M
 
Net Interest Expenses $1.7M -- -- -- $1.3M
EBT. Incl. Unusual Items -$3M -$1.8M -$6.6M -$10.2M -$33.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$34K -- -$33K $177K --
Net Income to Company -$3M -$1.8M -$6.6M -$10.4M -$33.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$3M -$1.8M -$6.6M -$10.4M -$33.2M
 
Basic EPS (Cont. Ops) -$0.68 -$0.05 -$0.19 -$0.30 -$0.69
Diluted EPS (Cont. Ops) -$0.68 -$0.05 -$0.19 -$0.30 -$0.69
Weighted Average Basic Share $4.4M $35.2M $34.5M $34.7M $47.8M
Weighted Average Diluted Share $4.4M $35.2M $34.5M $34.7M $47.8M
 
EBITDA -$1.2M -$1.7M -$6.1M -$9.8M -$29.3M
EBIT -$1.3M -$1.8M -$6.5M -$9.8M -$30.9M
 
Revenue (Reported) $1.9M $2M $2.9M $2.9M $3.7M
Operating Income (Reported) -$1.2M -$2.2M -$6.6M -$15.4M -$27.3M
Operating Income (Adjusted) -$1.3M -$1.8M -$6.5M -$9.8M -$30.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $12.3M $28.4M $10.7M $16.6M $24.5M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- $259K $968K $8.1M
Gross Profit $9M $26.4M $10.5M $15.6M $16.4M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $8.3M $10.4M $33.7M $34.9M $45.2M
Selling, General & Admin $6.8M $8.7M $12.8M $24.4M $53.4M
Other Inc / (Exp) -$680K -$16.3M -$495K $19.6M $535K
Operating Expenses $15M $19.1M $46.6M $59.4M $103.2M
Operating Income -$6M $7.4M -$36.1M -$43.8M -$86.7M
 
Net Interest Expenses $7.3M $1.8M -- -- $3.5M
EBT. Incl. Unusual Items -$14M -$10.7M -$35.9M -$19.7M -$89.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$42K -- -$718K $719K --
Net Income to Company -$13.9M -$10.7M -$35.2M -$20.4M -$89.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$13.9M -$10.7M -$35.2M -$20.4M -$89.7M
 
Basic EPS (Cont. Ops) -$5.22 -$4.07 -$0.89 -$0.60 -$2.11
Diluted EPS (Cont. Ops) -$5.22 -$4.07 -$0.89 -$0.60 -$2.11
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$6.3M -$8.5M -$35.1M -$18.3M -$78.2M
EBIT -$6.6M -$8.7M -$35.8M -$18.8M -$83.8M
 
Revenue (Reported) $12.3M $28.4M $10.7M $16.6M $24.5M
Operating Income (Reported) -$6M $7.4M -$36.1M -$43.8M -$86.7M
Operating Income (Adjusted) -$6.6M -$8.7M -$35.8M -$18.8M -$83.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $10.9M $26.1M $8.1M $14.5M $11.6M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.3M $2M $200K $946K $6.1M
Gross Profit $9.6M $24.1M $7.9M $13.6M $5.5M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $5.8M $7.4M $30.9M $28.4M $33.7M
Selling, General & Admin $5.4M $6.1M $10.3M $19.7M $38.7M
Other Inc / (Exp) -$895K -$16.2M -$548K $4.7M $4.7M
Operating Expenses $11.2M $13.5M $41.2M $48M $77.1M
Operating Income -$1.6M $10.6M -$33.3M -$34.4M -$71.6M
 
Net Interest Expenses $5.5M $366K -- -- $3.1M
EBT. Incl. Unusual Items -$7.9M -$5.9M -$33.3M -$26.2M -$69.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$34K -- -$752K -- --
Net Income to Company -$7.9M -$5.9M -$32.5M -$26.2M -$69.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$7.9M -$5.9M -$32.5M -$26.2M -$69.8M
 
Basic EPS (Cont. Ops) -$2.39 -$2.94 -$0.94 -$0.76 -$1.57
Diluted EPS (Cont. Ops) -$2.39 -$2.94 -$0.94 -$0.76 -$1.57
Weighted Average Basic Share $11.4M $83.5M $103.4M $103.1M $131.5M
Weighted Average Diluted Share $11.4M $83.5M $103.4M $103.1M $131.5M
 
EBITDA -$2.2M -$5.3M -$32.5M -$25.2M -$59.9M
EBIT -$2.4M -$5.5M -$33.1M -$25.4M -$64.6M
 
Revenue (Reported) $10.9M $26.1M $8.1M $14.5M $11.6M
Operating Income (Reported) -$1.6M $10.6M -$33.3M -$34.4M -$71.6M
Operating Income (Adjusted) -$2.4M -$5.5M -$33.1M -$25.4M -$64.6M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $3.2M $4.2M $112.3M $65.5M $43M
Short Term Investments -- -- -- $17.4M $24.7M
Accounts Receivable, Net $1.7M $2.4M $1.4M $7.2M $16.1M
Inventory -- -- -- -- --
Prepaid Expenses $516K $1.3M $930K $577K $1.2M
Other Current Assets $231K $203K $252K $1.1M $652K
Total Current Assets $7M $8.4M $115.1M $92.8M $86.9M
 
Property Plant And Equipment $3M $2.4M $2M $1.8M $1.5M
Long-Term Investments -- -- $15.4M $20M --
Goodwill -- -- -- -- $4.7M
Other Intangibles -- -- -- -- $69.2M
Other Long-Term Assets $527K $438K $438K $724K $9.9M
Total Assets $10.5M $11.2M $132.9M $115.3M $172.3M
 
Accounts Payable $1.1M $1.2M $516K $3.6M $14M
Accrued Expenses $3.8M $5.5M $2.5M $2.6M $14.4M
Current Portion Of Long-Term Debt -- $390K -- -- $37.7M
Current Portion Of Capital Lease Obligations $284K $499K $371K $480K $543K
Other Current Liabilities $236K -- $821K $5.4M $7.1M
Total Current Liabilities $5.4M $7.5M $4.2M $12M $73.7M
 
Long-Term Debt $77.3M $68M -- $12.8M $5.1M
Capital Leases -- -- -- -- --
Total Liabilities $85M $77.6M $5.8M $40.2M $110.5M
 
Common Stock -- -- $4K $3K $4K
Other Common Equity Adj -- -- -- $113K -$43K
Common Equity -$74.5M -$66.4M $127.1M $75.1M $61.9M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$74.5M -$66.4M $127.1M $75.1M $61.9M
 
Total Liabilities and Equity $10.5M $11.2M $132.9M $115.3M $172.3M
Cash and Short Terms $3.2M $4.2M $112.3M $82.8M $67.7M
Total Debt $77.3M $68.4M -- $12.8M $42.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $5.3M $131.5M $70.1M $43.3M $54M
Short Term Investments -- -- $5.8M $40.2M $35.3M
Accounts Receivable, Net $2.2M $1.6M $6.6M $9.9M $7.8M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $675K $1.5M $2.7M $1.7M $2.3M
Total Current Assets $8.1M $134.6M $85.1M $137M $99.4M
 
Property Plant And Equipment $2.4M $2.1M $1.9M $1.3M $1.4M
Long-Term Investments -- -- $31.5M -- $6.1M
Goodwill -- -- -- -- $4.7M
Other Intangibles -- -- -- -- $70.6M
Other Long-Term Assets $624K $439K $1M $629K $9.3M
Total Assets $11.2M $137.2M $119.6M $139M $191.6M
 
Accounts Payable -- -- -- -- --
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $65.9M -- -- -- --
Current Portion Of Capital Lease Obligations $532K $381K $474K $433K $540K
Other Current Liabilities -$1K $1.2M $3.7M $8.2M $9.5M
Total Current Liabilities $70.8M $3.7M $8.4M $21.7M $34.5M
 
Long-Term Debt $781K -- $12.8M $43.9M $58.9M
Capital Leases -- -- -- -- --
Total Liabilities $73.5M $5.4M $25.8M $71.5M $121.8M
 
Common Stock $7K $4K $3K $3K $5K
Other Common Equity Adj -- -- $201K -$220K -$115K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$62.3M $131.7M $93.8M $67.5M $69.8M
 
Total Liabilities and Equity $11.2M $137.2M $119.6M $139M $191.6M
Cash and Short Terms $5.3M $131.5M $75.9M $83.4M $89.4M
Total Debt $66.7M -- $12.8M $43.9M $58.9M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$24.5M -$12.8M -$8.6M -$26.8M -$46M
Depreciation & Amoritzation $304K $273K $257K $944K $1M
Stock-Based Compensation $4.4M $2.5M $2.4M $4.3M $6M
Change in Accounts Receivable -$1.7M -$714K $1.1M -$6.8M -$9.1M
Change in Inventories -- -- -- $147K $206K
Cash From Operations -$23.7M -$1.9M $10.4M -$18.7M -$33.5M
 
Capital Expenditures $26K $33K $102K $93K $296K
Cash Acquisitions -- -- -- -$14.1M -$30.4M
Cash From Investing $3.2M -$33K -$15.5M -$36.7M -$17.4M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $5.4M $3.1M -- $12.8M $42.4M
Long-Term Debt Repaid -$207K -$227K -$38.1M -$16K -$17.5M
Repurchase of Common Stock -- -- -$2.8M -$4.7M -$3.4M
Other Financing Activities -$300K -$118K $73.9M -$33K $692K
Cash From Financing $4.9M $2.7M $113.1M $8.4M $28.5M
 
Beginning Cash (CF) $19.1M $3.6M $4.3M $112.3M $65.5M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$15.6M $767K $108M -$47.1M -$22.5M
Ending Cash (CF) $3.6M $4.3M $112.3M $65.5M $43M
 
Levered Free Cash Flow -$23.8M -$2M $10.3M -$18.8M -$33.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$3M -$1.8M -$6.6M -$10.4M -$33.2M
Depreciation & Amoritzation $67K $65K $398K $62K $1.6M
Stock-Based Compensation $385K $620K $911K $1.4M $6.1M
Change in Accounts Receivable -$109K $269K -$3.4M $4.1M $1.2M
Change in Inventories -- -- $241K $65K -$583K
Cash From Operations -$1.1M -$2.7M -$6.6M -$4.6M -$18.1M
 
Capital Expenditures -- $4K $28K $172K --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -$4K $272K -$44.5M -$31.4M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $26M --
Long-Term Debt Repaid -$51K -$23K -$2K $205K --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- $930K -$407K -- --
Cash From Financing -$51K $1.9M -$409K $26.3M $64.8M
 
Beginning Cash (CF) $6.6M $132.3M $76.8M $66.2M $39.3M
Foreign Exchange Rate Adjustment -- -- $15K -$102K -$491K
Additions / Reductions -$1.1M -$792K -$6.7M -$22.8M $15.3M
Ending Cash (CF) $5.5M $131.5M $70.1M $43.3M $54M
 
Levered Free Cash Flow -$1.1M -$2.7M -$6.6M -$4.8M -$18.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$13.9M -$10.7M -$35.2M -$20.4M -$89.7M
Depreciation & Amoritzation $282K $259K $708K $519K $5.5M
Stock-Based Compensation $2.8M $2.1M $4.2M $5.4M $12.4M
Change in Accounts Receivable -$564K $583K -$4.6M -$3.8M $2.1M
Change in Inventories -- -- $280K $57K -$4.1M
Cash From Operations -$4M $10.2M -$15.1M -$21.8M -$69.6M
 
Capital Expenditures $12K $111K $76K $258K $72K
Cash Acquisitions -- -- -$14.1M -- --
Cash From Investing -$12K -$111K -$52.1M -$28M -$6.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $3.1M -- $12.8M $38.8M $62.6M
Long-Term Debt Repaid -$218K -$38.1M -$30K -$12.8M -$47.4M
Repurchase of Common Stock -- -- -$7.5M -$3.4M --
Other Financing Activities -- $74M -- $330K --
Cash From Financing $2.4M $115.9M $5.7M $23.2M $86.3M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.6M $126.1M -$61.5M -$26.7M $10.6M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$4M $10.1M -$15.2M -$22.1M -$69.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$7.9M -$5.9M -$32.5M -$26.2M -$69.8M
Depreciation & Amoritzation $207K $193K $644K $219K $4.7M
Stock-Based Compensation $2M $1.6M $3.3M $4.5M $10.9M
Change in Accounts Receivable -$337K $960K -$4.6M -$1.6M $9.6M
Change in Inventories -- -- $280K $190K -$4.2M
Cash From Operations -$880K $11.3M -$14.3M -$17.4M -$53.4M
 
Capital Expenditures $7K $85K $59K $224K --
Cash Acquisitions -- -- -$14.1M -- --
Cash From Investing -$7K -$85K -$36.7M -$28M -$16.7M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $3.1M -- $12.8M $38.8M $59M
Long-Term Debt Repaid -$168K -$38.1M -$13K -$12.8M -$42.7M
Repurchase of Common Stock -- -- -$4.7M -$3.4M --
Other Financing Activities -$131K $74M $329K $692K -$1.4M
Cash From Financing $2.8M $116M $8.6M $23.5M $81.3M
 
Beginning Cash (CF) $12.7M $212.6M $289.3M $171.8M $125.2M
Foreign Exchange Rate Adjustment -- -- $15K -$305K -$217K
Additions / Reductions $1.9M $127.2M -$42.3M -$21.9M $11.2M
Ending Cash (CF) $14.6M $339.8M $247.1M $149.6M $136.1M
 
Levered Free Cash Flow -$887K $11.2M -$14.3M -$17.6M -$53.4M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock